Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s): ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

TSX:ATE - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Share activity

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Feb 08, 2021 7:55pm

231 Views

Post# 32508356

RE:RE:Share activity

AntibeTribe wrote:

Jefnan1 wrote: There is no way today's activity has anything to do with the opening bell. I read the daily comments on here and can't believe the people who think the share movements either up or down have anything to do with the factors that effect a mature company on a daily basis. This is a speculative drug development company so if you believe the proof of concept than you shouldn't care what happens on a daily basis.

Obviously the opening bell didn't move the SP today. That's dumb. I dont think anyone here believes that's the case.. (+$.85 on a bell opening?? Shouldn't we just play opening bells everyday then? Lol)But nonetheless, something did act as a catalyst for the upward movement today.
We have traded sideways for months. Struggling with the $4 mark as a hurdle since the offering. (June 30, 2020)So with no news announced, aside from that of the opening bell, and nothing else changing today, we are left to assume that , as it was also today, the bell may have had a correlated affect on the SP. I personally don't think this is the case at all, and that bigger things are happening in the short term behind the curtain. Time will tell.

We also had this recently ... Dr. Stauffer also introduced OTEN and the Phase 2 trial results to many clinicians. Not saying this was part of it but it may have happened recently. Another reason there may be additional eyeballs on the company. No idea ... just saying it is part of this past weekend's activities.